Report Detail

Chemical & Material Global (United States, European Union and China) Healthcare Antimicrobial Plastics Market Research Report 2019-2025

  • RnM3703879
  • |
  • 28 August, 2019
  • |
  • Global
  • |
  • 126 Pages
  • |
  • QYResearch
  • |
  • Chemical & Material

Healthcare antimicrobial plastic are a type of polymer material infused with antimicrobial agents and additives such as organic-metallic biocides and arseni-based oxybisphenox arsine (OBPA). Antimicrobial plastic are mainly used to kill microorganisms such as bacteria, algae, and fungi, and inhibit their growth in the end-use products.
In 2019, the market size of Healthcare Antimicrobial Plastics is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Healthcare Antimicrobial Plastics.

This report studies the global market size of Healthcare Antimicrobial Plastics, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Healthcare Antimicrobial Plastics production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
BASF SE (Germany)
Bayer MaterialScience AG (Germany)
The Dow Chemical Company (US)
Clariant AG (Switzerland)
Lonza Group AG (Switzerland)
Microban International (US)
Parx Plastic BV (The Netherlands)
King Plastic Corporation (US)
Biocote (UK)
Milliken Chemical (US)
Sanitized AG (Switzerland)
PolyOne Corporation (US)
Ticona Engineering Polymers (US)
DSM (Netherlands)
Doeflex-Vitapol (UK)

Market Segment by Product Type
Commodity Plastic
Engineering Plastic
High Performance Plastic

Market Segment by Application
Hospital
Pharmacy
Household
Medical Research

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Healthcare Antimicrobial Plastics status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Healthcare Antimicrobial Plastics manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Healthcare Antimicrobial Plastics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025


Table of Contents

    1 Report Overview

    • 1.1 Research Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Healthcare Antimicrobial Plastics Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Commodity Plastic
      • 1.3.3 Engineering Plastic
      • 1.3.4 High Performance Plastic
    • 1.4 Market Segment by Application
      • 1.4.1 Global Healthcare Antimicrobial Plastics Market Share by Application (2019-2025)
      • 1.4.2 Hospital
      • 1.4.3 Pharmacy
      • 1.4.4 Household
      • 1.4.5 Medical Research
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Production and Capacity Analysis
      • 2.1.1 Global Healthcare Antimicrobial Plastics Production Value 2014-2025
      • 2.1.2 Global Healthcare Antimicrobial Plastics Production 2014-2025
      • 2.1.3 Global Healthcare Antimicrobial Plastics Capacity 2014-2025
      • 2.1.4 Global Healthcare Antimicrobial Plastics Marketing Pricing and Trends
    • 2.2 Key Producers Growth Rate (CAGR) 2019-2025
      • 2.2.1 Global Healthcare Antimicrobial Plastics Market Size CAGR of Key Regions
      • 2.2.2 Global Healthcare Antimicrobial Plastics Market Share of Key Regions
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Capacity and Production by Manufacturers
      • 3.1.1 Global Healthcare Antimicrobial Plastics Capacity by Manufacturers
      • 3.1.2 Global Healthcare Antimicrobial Plastics Production by Manufacturers
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Healthcare Antimicrobial Plastics Revenue by Manufacturers (2014-2019)
      • 3.2.2 Healthcare Antimicrobial Plastics Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Healthcare Antimicrobial Plastics Market Concentration Ratio (CR5 and HHI)
    • 3.3 Healthcare Antimicrobial Plastics Price by Manufacturers
    • 3.4 Key Manufacturers Healthcare Antimicrobial Plastics Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Healthcare Antimicrobial Plastics Market
    • 3.6 Key Manufacturers Healthcare Antimicrobial Plastics Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Production and Production Value for Each Type
      • 4.1.1 Commodity Plastic Production and Production Value (2014-2019)
      • 4.1.2 Engineering Plastic Production and Production Value (2014-2019)
      • 4.1.3 High Performance Plastic Production and Production Value (2014-2019)
    • 4.2 Global Healthcare Antimicrobial Plastics Production Market Share by Type
    • 4.3 Global Healthcare Antimicrobial Plastics Production Value Market Share by Type
    • 4.4 Healthcare Antimicrobial Plastics Ex-factory Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Healthcare Antimicrobial Plastics Consumption by Application

    6 Production by Regions

    • 6.1 Global Healthcare Antimicrobial Plastics Production (History Data) by Regions 2014-2019
    • 6.2 Global Healthcare Antimicrobial Plastics Production Value (History Data) by Regions
    • 6.3 United States
      • 6.3.1 United States Healthcare Antimicrobial Plastics Production Growth Rate 2014-2019
      • 6.3.2 United States Healthcare Antimicrobial Plastics Production Value Growth Rate 2014-2019
      • 6.3.3 Key Players in United States
      • 6.3.4 United States Healthcare Antimicrobial Plastics Import & Export
    • 6.4 European Union
      • 6.4.1 European Union Healthcare Antimicrobial Plastics Production Growth Rate 2014-2019
      • 6.4.2 European Union Healthcare Antimicrobial Plastics Production Value Growth Rate 2014-2019
      • 6.4.3 Key Players in European Union
      • 6.4.4 European Union Healthcare Antimicrobial Plastics Import & Export
    • 6.5 China
      • 6.5.1 China Healthcare Antimicrobial Plastics Production Growth Rate 2014-2019
      • 6.5.2 China Healthcare Antimicrobial Plastics Production Value Growth Rate 2014-2019
      • 6.5.3 Key Players in China
      • 6.5.4 China Healthcare Antimicrobial Plastics Import & Export
    • 6.6 Rest of World
      • 6.6.1 Japan
      • 6.6.2 Korea
      • 6.6.3 India
      • 6.6.4 Southeast Asia

    7 Healthcare Antimicrobial Plastics Consumption by Regions

    • 7.1 Global Healthcare Antimicrobial Plastics Consumption (History Data) by Regions
    • 7.2 United States
      • 7.2.1 United States Healthcare Antimicrobial Plastics Consumption by Type
      • 7.2.2 United States Healthcare Antimicrobial Plastics Consumption by Application
    • 7.3 European Union
      • 7.3.1 European Union Healthcare Antimicrobial Plastics Consumption by Type
      • 7.3.2 European Union Healthcare Antimicrobial Plastics Consumption by Application
    • 7.4 China
      • 7.4.1 China Healthcare Antimicrobial Plastics Consumption by Type
      • 7.4.2 China Healthcare Antimicrobial Plastics Consumption by Application
    • 7.5 Rest of World
      • 7.5.1 Rest of World Healthcare Antimicrobial Plastics Consumption by Type
      • 7.5.2 Rest of World Healthcare Antimicrobial Plastics Consumption by Application
      • 7.5.1 Japan
      • 7.5.2 Korea
      • 7.5.3 India
      • 7.5.4 Southeast Asia

    8 Company Profiles

    • 8.1 BASF SE (Germany)
      • 8.1.1 BASF SE (Germany) Company Details
      • 8.1.2 Company Description and Business Overview
      • 8.1.3 Production and Revenue of Healthcare Antimicrobial Plastics
      • 8.1.4 Healthcare Antimicrobial Plastics Product Introduction
      • 8.1.5 BASF SE (Germany) Recent Development
    • 8.2 Bayer MaterialScience AG (Germany)
      • 8.2.1 Bayer MaterialScience AG (Germany) Company Details
      • 8.2.2 Company Description and Business Overview
      • 8.2.3 Production and Revenue of Healthcare Antimicrobial Plastics
      • 8.2.4 Healthcare Antimicrobial Plastics Product Introduction
      • 8.2.5 Bayer MaterialScience AG (Germany) Recent Development
    • 8.3 The Dow Chemical Company (US)
      • 8.3.1 The Dow Chemical Company (US) Company Details
      • 8.3.2 Company Description and Business Overview
      • 8.3.3 Production and Revenue of Healthcare Antimicrobial Plastics
      • 8.3.4 Healthcare Antimicrobial Plastics Product Introduction
      • 8.3.5 The Dow Chemical Company (US) Recent Development
    • 8.4 Clariant AG (Switzerland)
      • 8.4.1 Clariant AG (Switzerland) Company Details
      • 8.4.2 Company Description and Business Overview
      • 8.4.3 Production and Revenue of Healthcare Antimicrobial Plastics
      • 8.4.4 Healthcare Antimicrobial Plastics Product Introduction
      • 8.4.5 Clariant AG (Switzerland) Recent Development
    • 8.5 Lonza Group AG (Switzerland)
      • 8.5.1 Lonza Group AG (Switzerland) Company Details
      • 8.5.2 Company Description and Business Overview
      • 8.5.3 Production and Revenue of Healthcare Antimicrobial Plastics
      • 8.5.4 Healthcare Antimicrobial Plastics Product Introduction
      • 8.5.5 Lonza Group AG (Switzerland) Recent Development
    • 8.6 Microban International (US)
      • 8.6.1 Microban International (US) Company Details
      • 8.6.2 Company Description and Business Overview
      • 8.6.3 Production and Revenue of Healthcare Antimicrobial Plastics
      • 8.6.4 Healthcare Antimicrobial Plastics Product Introduction
      • 8.6.5 Microban International (US) Recent Development
    • 8.7 Parx Plastic BV (The Netherlands)
      • 8.7.1 Parx Plastic BV (The Netherlands) Company Details
      • 8.7.2 Company Description and Business Overview
      • 8.7.3 Production and Revenue of Healthcare Antimicrobial Plastics
      • 8.7.4 Healthcare Antimicrobial Plastics Product Introduction
      • 8.7.5 Parx Plastic BV (The Netherlands) Recent Development
    • 8.8 King Plastic Corporation (US)
      • 8.8.1 King Plastic Corporation (US) Company Details
      • 8.8.2 Company Description and Business Overview
      • 8.8.3 Production and Revenue of Healthcare Antimicrobial Plastics
      • 8.8.4 Healthcare Antimicrobial Plastics Product Introduction
      • 8.8.5 King Plastic Corporation (US) Recent Development
    • 8.9 Biocote (UK)
      • 8.9.1 Biocote (UK) Company Details
      • 8.9.2 Company Description and Business Overview
      • 8.9.3 Production and Revenue of Healthcare Antimicrobial Plastics
      • 8.9.4 Healthcare Antimicrobial Plastics Product Introduction
      • 8.9.5 Biocote (UK) Recent Development
    • 8.10 Milliken Chemical (US)
      • 8.10.1 Milliken Chemical (US) Company Details
      • 8.10.2 Company Description and Business Overview
      • 8.10.3 Production and Revenue of Healthcare Antimicrobial Plastics
      • 8.10.4 Healthcare Antimicrobial Plastics Product Introduction
      • 8.10.5 Milliken Chemical (US) Recent Development
    • 8.11 Sanitized AG (Switzerland)
    • 8.12 PolyOne Corporation (US)
    • 8.13 Ticona Engineering Polymers (US)
    • 8.14 DSM (Netherlands)
    • 8.15 Doeflex-Vitapol (UK)

    9 Market Forecast

    • 9.1 Global Market Size Forecast
      • 9.1.1 Global Healthcare Antimicrobial Plastics Capacity, Production Forecast 2019-2025
      • 9.1.2 Global Healthcare Antimicrobial Plastics Production Value Forecast 2019-2025
    • 9.2 Market Forecast by Regions
      • 9.2.1 Global Healthcare Antimicrobial Plastics Production and Value Forecast by Regions 2019-2025
      • 9.2.2 Global Healthcare Antimicrobial Plastics Consumption Forecast by Regions 2019-2025
    • 9.3 United States
      • 9.3.1 Production and Value Forecast in United States
      • 9.3.2 Consumption Forecast in United States
    • 9.4 European Union
      • 9.4.1 Production and Value Forecast in European Union
      • 9.4.2 Consumption Forecast in European Union
    • 9.5 China
      • 9.5.1 Production and Value Forecast in China
      • 9.5.2 Consumption Forecast in China
    • 9.6 Rest of World
      • 9.6.1 Japan
      • 9.6.2 Korea
      • 9.6.3 India
      • 9.6.4 Southeast Asia
    • 9.7 Forecast by Type
      • 9.7.1 Global Healthcare Antimicrobial Plastics Production Forecast by Type
      • 9.7.2 Global Healthcare Antimicrobial Plastics Production Value Forecast by Type
    • 9.8 Consumption Forecast by Application

    10 Value Chain and Sales Channels Analysis

    • 10.1 Value Chain Analysis
    • 10.2 Sales Channels Analysis
      • 10.2.1 Healthcare Antimicrobial Plastics Sales Channels
      • 10.2.2 Healthcare Antimicrobial Plastics Distributors
    • 10.3 Healthcare Antimicrobial Plastics Customers

    11 Opportunities & Challenges, Threat and Affecting Factors

    • 11.1 Market Opportunities
    • 11.2 Market Challenges
    • 11.3 Porter's Five Forces Analysis

    12 Key Findings

      13 Appendix

      • 13.1 Research Methodology
        • 13.1.1 Methodology/Research Approach
          • 13.1.1.1 Research Programs/Design
          • 13.1.1.2 Market Size Estimation
          • 13.1.1.3 Market Breakdown and Data Triangulation
        • 13.1.2 Data Source
          • 13.1.2.1 Secondary Sources
          • 13.1.2.2 Primary Sources
      • 13.2 Author Details

      Summary:
      Get latest Market Research Reports on Healthcare Antimicrobial Plastics. Industry analysis & Market Report on Healthcare Antimicrobial Plastics is a syndicated market report, published as Global (United States, European Union and China) Healthcare Antimicrobial Plastics Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Healthcare Antimicrobial Plastics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,280.00
      $4,920.00
      $6,560.00
      2,578.08
      3,867.12
      5,156.16
      3,099.60
      4,649.40
      6,199.20
      509,056.00
      763,584.00
      1,018,112.00
      276,963.20
      415,444.80
      553,926.40
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report